Publication | Open Access
Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib
424
Citations
20
References
2011
Year
In this study, CML-related deaths were uncommon in CML patients who were in CCyR 2 years after starting imatinib, and survival was not statistically significantly different from that of the general population.
| Year | Citations | |
|---|---|---|
Page 1
Page 1